These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 20630073

  • 1. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
    Chaudhary AK, Singh M, Bharti AC, Singh M, Shukla S, Singh AK, Mehrotra R.
    BMC Cancer; 2010 Jul 14; 10():369. PubMed ID: 20630073
    [Abstract] [Full Text] [Related]

  • 2. Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.
    Chaudhary AK, Pandya S, Mehrotra R, Singh M, Singh M.
    Biomarkers; 2011 Nov 14; 16(7):577-86. PubMed ID: 21958210
    [Abstract] [Full Text] [Related]

  • 3. Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population.
    Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Jain S, Singh M.
    Biomarkers; 2010 Dec 14; 15(8):684-92. PubMed ID: 20860530
    [Abstract] [Full Text] [Related]

  • 4. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
    Zhang J, Jin X, Fang S, Li Y, Wang R, Guo W, Wang N, Wang Y, Wen D, Wei L, Kuang G, Dong Z.
    Carcinogenesis; 2004 Dec 14; 25(12):2519-24. PubMed ID: 15319302
    [Abstract] [Full Text] [Related]

  • 5. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
    Fang SM, Jin X, Li Y, Wang R, Guo W, Wang N, Zhang JH.
    Ai Zheng; 2005 Mar 14; 24(3):305-10. PubMed ID: 15757531
    [Abstract] [Full Text] [Related]

  • 6. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
    Kang S, Wang Y, Zhang JH, Jin X, Fang SM, Li Y.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep 14; 40(9):601-4. PubMed ID: 16202315
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Matrix metalloproteinases-3 gene-promoter polymorphism as a risk factor in oral submucous fibrosis in an Indian population: a pilot study.
    Zade PR, Gosavi SR, Hazarey VK, Ganvir SM.
    J Investig Clin Dent; 2017 Aug 14; 8(3):. PubMed ID: 27389714
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers.
    Luizon MR, de Almeida Belo V.
    Biomarkers; 2012 May 14; 17(3):286-8. PubMed ID: 22309315
    [Abstract] [Full Text] [Related]

  • 13. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
    Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R.
    Clin Cancer Res; 2002 Dec 14; 8(12):3820-3. PubMed ID: 12473595
    [Abstract] [Full Text] [Related]

  • 14. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
    Hashimoto T, Uchida K, Okayama N, Imate Y, Suehiro Y, Hamanaka Y, Ueyama Y, Shinozaki F, Yamashita H, Hinoda Y.
    Cancer Lett; 2004 Jul 28; 211(1):19-24. PubMed ID: 15194213
    [Abstract] [Full Text] [Related]

  • 15. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.
    Szyllo K, Smolarz B, Romanowicz-Makowska H, Niewiadomski M, Kozlowska E, Kulig A.
    J Exp Clin Cancer Res; 2002 Sep 28; 21(3):357-61. PubMed ID: 12385578
    [Abstract] [Full Text] [Related]

  • 16. [Association of matrix metalloproteinase-3 serum level and the promoter 5A/6A polymorphism of the MMP-3 gene with atherosclerotic cerebral infarction].
    Huang X, Zhu M, Jin X, Zhang D, Wang L, Ye Z.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec 28; 25(6):653-6. PubMed ID: 19065524
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.
    Gantala SR, Kondapalli MS, Kummari R, Padala C, Tupurani MA, Kupsal K, Galimudi RK, Gundapaneni KK, Puranam K, Shyamala N, Guditi S, Rapur R, Hanumanth SR.
    Gene; 2018 Oct 05; 673():22-31. PubMed ID: 29883760
    [Abstract] [Full Text] [Related]

  • 20. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
    Tu HF, Wu CH, Kao SY, Liu CJ, Liu TY, Lui MT.
    J Oral Pathol Med; 2007 Aug 05; 36(7):409-14. PubMed ID: 17617834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.